ENTITY

Tiziana Life Sciences (TILS LN)

Health CareUnited Kingdom
Tiziana Life Sciences plc, a clinical stage biotechnology company, focuses on the discovery and development of novel therapeutics for cancer in the United Kingdom. The company?s product candidate includes Milciclib that is in phase II clinical trials for thymic carcinoma in patients previously treated with chemotherapy. It also develops Foralumab, a human anti-CD3 antibody, which is in phase II clinical stage for autoimmune and inflammatory diseases, such as ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel disease, psoriasis, and rheumatoid arthritis; and Bcl-3 for use in metastasis of mammary cancers. The company is based in London, the United Kingdom. Tiziana Life Sciences plc is a subsidiary of Planwise Group Limited.
more
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
x